array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(28) "Bristol-Myers Squibb Company"
["slug"]=>
string(37) "81631-us-bristol-myers-squibb-company"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13"
["description"]=>
string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome.
Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.
Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do.
Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html"
["address_street"]=>
string(19) "430 E 29TH St FL 14"
["address_place"]=>
string(8) "New York"
["address_region"]=>
string(8) "New York"
["founding_date"]=>
string(10) "1887-02-28"
["website_domain"]=>
string(7) "bms.com"
["website_url"]=>
string(19) "https://www.bms.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(1200)
["article_count"]=>
int(2495)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(109) "The Zacks Analyst Blog Highlights Microsoft, Booking Holdings, Bristol-Myers Squibb, Equifax hand First Solar"
["snippet_en"]=>
string(110) "Microsoft, Booking Holdings, Bristol-Myers Squibb, Equifax hand First Solar are included in this Analyst Blog."
["url"]=>
string(85) "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-094900926.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/aa9da751-ee77-4e00-89a7-b4f58610bc8d"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-12-21"
["categories"]=>
array(1) {
[0]=>
string(15) "Blogs & Columns"
}
}
[1]=>
array(7) {
["title_en"]=>
string(98) "The Zacks Analyst Blog Highlights Mastercard, SAP, Texas Instruments, Bristol-Myers Squibb and ATT"
["snippet_en"]=>
string(100) "Mastercard, SAP, Texas Instruments, Bristol-Myers Squibb and AT&T are included in this Analyst Blog."
["url"]=>
string(86) "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-mastercard-091200606.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/269c5967-f43c-4f8f-8670-cde979e7bf36"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-09-13"
["categories"]=>
array(1) {
[0]=>
string(15) "Blogs & Columns"
}
}
[2]=>
array(7) {
["title_en"]=>
string(69) "Bristol-Myers Squibb Co. v. New Mexico, ex rel. Balderas - SCOTUSblog"
["snippet_en"]=>
string(43) "The Supreme Court of the United States blog"
["url"]=>
string(97) "https://www.scotusblog.com/case-files/cases/bristol-myers-squibb-co-v-new-mexico-ex-rel-balderas/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ed7b87d8-9ad6-4cbe-963a-cbd93051636d"
["source"]=>
string(14) "scotusblog.com"
["publication_date"]=>
string(10) "2020-09-19"
["categories"]=>
array(4) {
[0]=>
string(5) "Legal"
[1]=>
string(8) "Verdicts"
[2]=>
string(46) "Management of Legal and Regulatory Environment"
[3]=>
string(15) "Blogs & Columns"
}
}
[3]=>
array(7) {
["title_en"]=>
string(93) "The Zacks Analyst Blog Highlights: TransDigm, Keysight, Bristol-Myers Squibb, NRG and Arconic"
["snippet_en"]=>
string(248) "For Immediate Release. Chicago, IL -September 4, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets."
["url"]=>
string(130) "https://www.nasdaq.com/article/the-zacks-analyst-blog-highlights-transdigm-keysight-bristol-myers-squibb-nrg-and-arconic-cm1207200"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2019-09-04"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Blogs & Columns"
}
}
[4]=>
array(7) {
["title_en"]=>
string(117) "The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Alamos Gold, Americold Realty Trust, TransDigm and frontdoor"
["snippet_en"]=>
string(247) "For Immediate Release. Chicago, IL - August 30, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets."
["url"]=>
string(152) "https://m.nasdaq.com/article/the-zacks-analyst-blog-highlights-bristol-myers-squibb-alamos-gold-americold-realty-trust-transdigm-and-frontdoor-cm1205872"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2019-08-30"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Blogs & Columns"
}
}
[5]=>
array(7) {
["title_en"]=>
string(119) "The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, ONEOK, Verizon Communications, Principal Financial and Omnicom"
["snippet_en"]=>
string(247) "For Immediate Release. Chicago, IL - August 30, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets."
["url"]=>
string(156) "https://www.nasdaq.com/article/the-zacks-analyst-blog-highlights-bristol-myers-squibb-oneok-verizon-communications-principal-financial-and-omnicom-cm1205873"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2019-08-30"
["categories"]=>
array(3) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(14) "Product Launch"
[2]=>
string(15) "Blogs & Columns"
}
}
[6]=>
array(7) {
["title_en"]=>
string(47) "Murco Wall Products Inc. v. Galier - SCOTUSblog"
["snippet_en"]=>
string(43) "The Supreme Court of the United States blog"
["url"]=>
string(77) "https://www.scotusblog.com/case-files/cases/murco-wall-products-inc-v-galier/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0c3ab341-6cd3-41f0-bb01-97c4b4374841"
["source"]=>
string(14) "scotusblog.com"
["publication_date"]=>
string(10) "2017-09-17"
["categories"]=>
array(5) {
[0]=>
string(5) "Legal"
[1]=>
string(8) "Verdicts"
[2]=>
string(10) "Litigation"
[3]=>
string(15) "Blogs & Columns"
[4]=>
string(46) "Management of Legal and Regulatory Environment"
}
}
[7]=>
array(7) {
["title_en"]=>
string(105) "The Zacks Analyst Blog Highlights:Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and Pfizer"
["snippet_en"]=>
string(160) "/PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and..."
["url"]=>
string(156) "https://www.prnewswire.com/news-releases/the-zacks-analyst-blog-highlightsstarbucks-dunkin-brands-bristol-myers-squibb-astrazeneca-and-pfizer-268588272.html"
["image_url"]=>
NULL
["source"]=>
string(14) "prnewswire.com"
["publication_date"]=>
string(10) "2014-07-25"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Blogs & Columns"
}
}
[8]=>
array(7) {
["title_en"]=>
string(95) "The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Merck, Roche, Pharmacyclics and AbbVie"
["snippet_en"]=>
string(160) "/PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and..."
["url"]=>
string(147) "https://www.prnewswire.com/news-releases/the-zacks-analyst-blog-highlights-bristol-myers-squibb-merck-roche-pharmacyclics-and-abbvie-261817041.html"
["image_url"]=>
NULL
["source"]=>
string(14) "prnewswire.com"
["publication_date"]=>
string(10) "2014-06-04"
["categories"]=>
array(2) {
[0]=>
string(24) "Stock Research & Ratings"
[1]=>
string(15) "Blogs & Columns"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(254)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(163)
}
[2]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(151)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(94)
}
[4]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(89)
}
[5]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(76)
}
[6]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(74)
}
[7]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(64)
}
[8]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(63)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(60)
}
[10]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(60)
}
[11]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(56)
}
[12]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(54)
}
[13]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(47)
}
[14]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(47)
}
[15]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(45)
}
[16]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(45)
}
[17]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(42)
}
[18]=>
array(2) {
["name"]=>
string(8) "Verdicts"
["count"]=>
int(39)
}
[19]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(35)
}
[20]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(35)
}
[21]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(33)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(32)
}
[23]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(28)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(27)
}
[25]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(26)
}
[26]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(24)
}
[27]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(22)
}
[28]=>
array(2) {
["name"]=>
string(9) "Valuation"
["count"]=>
int(21)
}
[29]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(21)
}
}
}
81631-us-bristol-myers-squibb-company
Bristol-Myers Squibb Company
Location
New York
Founded
1887-02-28
Website
https://www.bms.com
Articles
2495 Articles
Category
Pharmaceutical Preparations
Description
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome.
Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients.
Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do.
Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
For Immediate Release. Chicago, IL -September 4, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
For Immediate Release. Chicago, IL - August 30, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
For Immediate Release. Chicago, IL - August 30, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
/PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
/PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
